Methylphenidate hydrochloride
Synonym(s):threo-Methyl α-phenyl-α-(2-piperidyl)acetate hydrochloride;Ritalin hydrochloride
- CAS NO.:298-59-9
- Empirical Formula: C14H20ClNO2
- Molecular Weight: 269.77
- MDL number: MFCD00058191
- EINECS: 206-065-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2024-01-17 16:57:51
What is Methylphenidate hydrochloride?
Chemical properties
white crystalline powder
Originator
Ritalin,Ciba,US,1958
The Uses of Methylphenidate hydrochloride
antiinflammatory
The Uses of Methylphenidate hydrochloride
Controlled substance (stimulant). CNS stimulant. Four isomers of Methylphenidate are known to exist. One pair of threo isomers and one pair of erythro are distinguished, from which only d-threo-Methyl phenidate exhibits the pharmacologically usually desired effects.
The Uses of Methylphenidate hydrochloride
Methylphenidate (a.k.a., Ritalin) is a schedule II drug in the United States commonly used as a psychostimulant for the treatment of attention-deficit hyperactivity disorder. It blocks dopamine and norepinephrine transporters as well as facilitates NMDA-receptor mediated synaptic transmission through σ1 receptors via PLC/PKC signaling. This interaction with the σ1 receptor has been suggested to underlie methylphenidate’s considerable abuse potential and potential psychiatric side effects. This product is intended for forensic and biological research applications.[Cayman Chemical]
Manufacturing Process
As described in US Patent 2,507,631, 80 g of pulverized sodium amide are gradually added, while stirring and cooling, to a solution of 117 g of phenylacetonitrile and 113 g of 2-chloropyridine in 400 cc of absolute toluene. The mixture is then slowly heated to 110° to 120°C and maintained at this temperature for 1 hour. Water is added thereto after cooling, the toluene solution is shaken with dilute hydrochloric acid and the hydrochloric acid extracts are made alkaline with concentrated caustic soda solution. A solid mass is separated thereby which is taken up in acetic ester and distilled, αphenyl-α-pyridyl-(2)-acetonitrile passing over at 150° to 155°C under 0.5 mm pressure. When recrystallized from ethyl acetate it melts at 88° to 89°C, the
yield amounting to 135 g.
100 g of α-phenyl-α-pyridyl-(2)-acetonitrile are introduced into 400 cc of
concentrated sulfuric acid, allowed to stand overnight at room temperature,
poured into ice and rendered alkaline with sodium carbonate. α-Phenyl-αpyridyl-(2)-acetamide is precipitated thereby which melts at 134°C after
recrystallization from ethyl acetate.
100g of the resulting α-phenyl-α-pyridyl-(2)-acetamide, when dissolved in one
liter of methyl alcohol and treated for 6 hours at water-bath temperature with
hydrogen chloride, and after concentrating, diluting with water and rendering
alkaline with sodium carbonate, yield 90 g of the α-phenyl-α-pyridyl-(2)-acetic
acid methylester of MP 74° to 75°C (from alcohol of 50% strength).
The α-phenyl-α-piperidyl-(2)-acetic acid methylester of BP 135° to 137°C
under 0.6 mm pressure is obtained in theoretical yield by hydrogenation of 50
g of α-phenyl-α-pyridyl(2)-acetic acid methylester in glacial acetic acid in the
presence of 1 g of platinum catalyst at room temperature, while taking up 6
hydrogen atoms. Reaction with HCl gives the hydrochloride. Resolution of
stereoisomers is described in US Patent 2,957,880.
Therapeutic Function
Psychostimulant
General Description
Odorless white crystalline powder. Metallic taste. Solutions are acid to litmus. Absence of general acid/base catalysis.
General Description
Because methylphenidate (Ritalin) has two asymmetriccenters, there are four possible isomers. The threo racemateis the marketed compound and is about 400 times aspotent as the erythro racemate.The absolute configurationof each of the threo-methylphenidate isomers has beendetermined.Considering that the structure is fairly complex(relative to amphetamine), it is likely that one of thetwo components of the threo racemate contains most of theactivity. Evidence indicates that the (+) -(2R,2'R)threoisomer is involved principally in the behavioral andpressor effects of the racemate.As is likely with many central psychomotor stimulants, there are multiple modesof action.
Methylphenidate, probably largely via its p-hydroxymetabolite, blocks NE reuptake, acts as a postsynapticagonist, depletes the same NE pools as reserpine, and haseffects on dopaminergic systems, such as blocking DAreuptake.
Methylphenidate is a potent CNS stimulant. Indicationsinclude narcolepsy and attention-deficit disorder.
Air & Water Reactions
Water soluble.
Reactivity Profile
Methylphenidate hydrochloride is incompatible with alkalis and solutions of barbiturates . Undergoes typical ester hydrolysis in aqueous solutions at 176°F.
Fire Hazard
Flash point data for Methylphenidate hydrochloride are not available; however, Methylphenidate hydrochloride is probably combustible.
Biological Activity
Psychomotor stimulant. Inhibitor of dopamine and noradrenalin transporters that increases the extracellular concentration of dopamine and noradrenalin. Increases locomotor activity in vivo .
Veterinary Drugs and Treatments
Methylphenidate may be useful for treating cataplexy/narcolepsy or hyperactivity in dogs.
storage
Store at RT
Properties of Methylphenidate hydrochloride
Melting point: | 196-198?C |
Flash point: | 9℃ |
storage temp. | Store at RT |
solubility | Freely soluble in water, soluble in ethanol (96 per cent), slightly soluble in methylene chloride. |
form | Powder |
pka | 8.9(at 25℃) |
Water Solubility | Soluble to 50 mM in water and to 100 mM in ethanol |
Stability: | Stable. Combustible. Incompatible with strong oxidizing agents, alkalies, barbiturates. |
InChI | InChI=1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H |
CAS DataBase Reference | 298-59-9(CAS DataBase Reference) |
EPA Substance Registry System | Methylphenidate hydrochloride (298-59-9) |
Safety information for Methylphenidate hydrochloride
Signal word | Danger |
Pictogram(s) |
Exclamation Mark Irritant GHS07 Health Hazard GHS08 |
GHS Hazard Statements |
H302:Acute toxicity,oral H334:Sensitisation, respiratory |
Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P270:Do not eat, drink or smoke when using this product. P284:Wear respiratory protection. P301+P312:IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. P501:Dispose of contents/container to..… |
Computed Descriptors for Methylphenidate hydrochloride
InChIKey | JUMYIBMBTDDLNG-UHFFFAOYSA-N |
SMILES | C(C(=O)OC)(C1NCCCC1)C1C=CC=CC=1.Cl |
Abamectin manufacturer
Malladi Drugs AND Pharmaceuticals Limited
Centaur Pharmaceuticals Pvt Ltd
Cohance Lifesciences (Previously RA Chem Pharma Ltd)
New Products
4-Aminotetrahydropyran-4-carbonitrile Hydrochloride (R)-3-Aminobutanenitrile Hydrochloride 4-AMINO-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HCL 4-(Dimethylamino)tetrahydro-2H-pyran-4-carbonitrile 3-((Dimethylamino)methyl)-5-methylhexan-2-one oxalate 1,4-Dioxa-8-azaspiro[4.5]decane 5-Bromo-2-nitropyridine Nimesulide BP Aceclofenac IP/BP/EP Diclofenac Sodium IP/BP/EP/USP Mefenamic Acid IP/BP/EP/USP Ornidazole IP Diclofenac Potassium SODIUM AAS SOLUTION ZINC AAS SOLUTION BUFFER SOLUTION PH 10.0(BORATE) GOOCH CRUCIBLE SINTERED AQUANIL 5 BERYLLIUM AAS SOLUTION 2-Bromo-1-(bromomethyl)-3-chloro-5-nitrobenzene 2-Bromo-3-nitroaniline N-(3-Hydroxypropyl)-N-methylacetamide 3-Bromo-6-chloropyridazine 4-ethyl-3-nitrobenzoic acidRelated products of tetrahydrofuran
You may like
-
298-59-9 Methylphenidate hydrochloride 98%View Details
298-59-9 -
298-59-9 98%View Details
298-59-9 -
Methylphenidate hydrochloride 99%View Details
298-59-9 -
Methylphenidate hydrochloride 298-59-9 99%View Details
298-59-9 -
298-59-9 Methylphenidate hydrochloride 98%View Details
298-59-9 -
298-59-9 98%View Details
298-59-9 -
Methylphenidate hydrochloride 98%View Details
298-59-9 -
Lithium ClavulanateView Details
61177-44-4